The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects

被引：0
|
作者：
Bo Tan
Yi-Fan Zhang
Xiao-Yan Chen
Xiao-Hua Zhao
Guo-Xin Li
Da-Fang Zhong
机构：
[1] Chinese Academy of Sciences,Shanghai Institute of Materia Medica
[2] Liaoning University of Traditional Chinese Medicine,Departmant of Clinical Pharmacology, The Second Affiliated Hospital
来源：
European Journal of Clinical Pharmacology | 2010年 / 66卷
关键词：
Glipizide; Genetic polymorphism; Pharmacokinetics; Pharmacodynamics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：145 / 151
页数：6
相关论文
共 50 条
  • [31] Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro:: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism
    Shon, JH
    Yoon, YR
    Kim, MJ
    Kim, KA
    Lim, YC
    Liu, KH
    Shin, DH
    Lee, CH
    Cha, IJ
    Shin, JG
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 552 - 563
  • [32] Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population
    Kudzi, William
    Dodoo, Alexander N. O.
    Mills, Jeremy J.
    BMC MEDICAL GENETICS, 2009, 10
  • [33] Pharmacokinetics and pharmacodynamics of tolbutamide and chlorpropamide in relation to CYP2C9 and CYP2C19.
    Yoon, YR
    Shon, JH
    Kim, KA
    Cha, IJ
    Shin, SG
    Shin, JG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 152 - 152
  • [34] Genetic Polymorphisms and in Vitro Functional Characterization of CYP2C8, CYP2C9, and CYP2C19 Allelic Variants
    Hiratsuka, Masahiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (11) : 1748 - 1759
  • [35] Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance
    Scordo, MG
    Pengo, V
    Spina, E
    Dahl, ML
    Gusella, M
    Padrini, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (06) : 702 - 710
  • [36] Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans
    Shon, JH
    Yoon, YR
    Kim, KA
    Lim, YC
    Lee, KJ
    Park, JY
    Cha, IJ
    Flockhart, DA
    Shin, JG
    PHARMACOGENETICS, 2002, 12 (02): : 111 - 119
  • [37] A meta-analysis of effects of CYP2C9 and CYP2C19 polymorphisms on phenytoin pharmacokinetic parameters
    Kanjanasilp, Juntip
    Sawangjit, Ratree
    Phanthaisong, Sirikhwan
    Borihanthanawuth, Wongvaruth
    PHARMACOGENOMICS, 2021, 22 (10) : 629 - 640
  • [38] Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study
    Vicente, Jorge
    Gonzalez-Andrade, Fabricio
    Soriano, Antonia
    Fanlo, Ana
    Martinez-Jarreta, Begona
    Sinues, Blanca
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (03) : 1267 - 1272
  • [39] Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study
    Jorge Vicente
    Fabricio González-Andrade
    Antonia Soriano
    Ana Fanlo
    Begoña Martínez-Jarreta
    Blanca Sinués
    Molecular Biology Reports, 2014, 41 : 1267 - 1272
  • [40] Effects of CYP2C19, CYP2C9 and CYP3A4 gene polymorphisms on plasma voriconazole levels in Chinese pediatric patients
    Fan, Xinghua
    Zhang, Hong
    Wen, Zhipeng
    Zheng, Xiaoli
    Yang, Yi
    Yang, Jihong
    PHARMACOGENETICS AND GENOMICS, 2022, 32 (04): : 152 - 158
12345